 |
170 medics attend professional conferenceMore than 170 medical professionals from UAE’ s diabetes medical community of interest attended a professional scientific conference jointly hosted by Moorfields Eye Hospital Dubai and Novartis at the JW Marriott Marquis Dubai. More… |
 |
Indian court dismisses Novartis patent pleaIndia's top court rejected Swiss drugmaker Novartis AG's plea for patent protection of its cancer drug Glivec, a move likely to boost the prospects of Indian pharmaceutical firms over their foreign rivals. More… |
 |
Novartis Egypt launches tree planting driveNovartis Egypt, the Egyptian affiliate of Swiss-based Novartis, recently marked its 16th annual Community Partnership Day with the launch of a tree planting initiative. Nearly 400 Novartis employees planted 150 trees using sustainable agri More… |
 |
New warnings on Novartis MS pillEuropean and US regulators have backed the continued use of Novartis AG's multiple sclerosis pill Gilenya, one of the Swiss firm's top new drug hopes, but said the drug needed to carry stronger warnings on heart risks. Novartis said More… |
 |
UAE sets up task force to combat MSThe Emirates Neurology Society (Emins) has set up the first-ever national taskforce to tackle multiple sclerosis (MS), a nervous system disease with no known cause that affects the brain and spinal cord, in the UAE. Acting under the umbrel More… |
 |
Novartis announces massive US jobs cutsNovartis AG is slashing nearly 2,000 jobs in the US ahead of the patent loss of its top-selling blood pressure drug Diovan, the Swiss drugmaker said on Friday, just months after it said would scale back operations in Switzerland. The group More… |
 |
Breast cancer victims ‘can double survival time’Women suffering from breast cancer can survive for twice as long without disease progression using the Novartis-made drug Afinitor (everolimus) in conjunction with hormonal therapy, said a new study. The risk of cancer progression was redu More… |
 |
IBM, Novartis challenge students on diseasesIBM and Novartis have announced the NCD Challenge, a competition among a number of the world’s leading universities designed to tap the inventiveness of students to find new ways to address the rise of non-communicable diseases in both developing More… |
 |
Novartis drug guards against meningitis causeNovartis’ Bexsero vaccine helps protect toddlers against the most common cause of meningitis when used as a booster, the Swiss drugmaker said on Thursday based on a study, giving its meningitis franchise another lift. A late-stage study sh More… |
 |
Novartis drug gives pain relief in gouty arthritisNovartis AG's gout treatment hopeful gives patients better pain relief and significantly cuts the risk of new attacks, two late stage studies showed, giving the drugmaker's pipeline another boost. Ilaris, or ACZ885, is seen as a key drug f More… |
